Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Marcela Maus , MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass ...

Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts ...

Bengaluru: In a landmark development for cancer care in India and for Chimeric Antigen Receptor T-cell (CAR T) therapy, two patients in Bengaluru have completed three years ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya University in Japan and ...